Metagenomi Therapeutics, Inc. (MGX)
1.02
+0.02
(+2.00%)
USD |
NASDAQ |
Oct 12, 16:00
1.02
0.00 (0.00%)
After-Hours: 20:00
Metagenomi Therapeutics Price : 1.02 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 0.9968 | 1.06 | 0.9901 | 1.02 | 150974.0 |
| Oct 09, 2026 | 0.99 | 1.04 | 0.99 | 1.00 | 147176.0 |
| Oct 08, 2026 | 1.00 | 1.01 | 0.9601 | 0.9932 | 354863.0 |
| Oct 07, 2026 | 1.01 | 1.02 | 0.96 | 0.9847 | 270312.0 |
| Oct 06, 2026 | 1.07 | 1.08 | 1.025 | 1.03 | 121027.0 |
| Oct 05, 2026 | 1.01 | 1.06 | 1.01 | 1.04 | 163205.0 |
| Oct 02, 2026 | 1.09 | 1.095 | 1.015 | 1.02 | 121954.0 |
| Oct 01, 2026 | 1.06 | 1.11 | 1.06 | 1.105 | 118332.0 |
| Sep 30, 2026 | 1.13 | 1.135 | 1.06 | 1.06 | 152290.0 |
| Sep 29, 2026 | 1.13 | 1.149 | 1.103 | 1.13 | 56685.00 |
| Sep 28, 2026 | 1.13 | 1.16 | 1.13 | 1.14 | 135966.0 |
| Sep 25, 2026 | 1.14 | 1.165 | 1.14 | 1.15 | 70806.00 |
| Sep 24, 2026 | 1.12 | 1.165 | 1.12 | 1.15 | 211649.0 |
| Sep 23, 2026 | 1.14 | 1.145 | 1.12 | 1.13 | 100338.0 |
| Sep 22, 2026 | 1.07 | 1.16 | 1.07 | 1.14 | 165230.0 |
| Sep 21, 2026 | 1.11 | 1.14 | 1.092 | 1.12 | 103275.0 |
| Sep 18, 2026 | 1.12 | 1.14 | 1.10 | 1.10 | 124385.0 |
| Sep 17, 2026 | 1.15 | 1.165 | 1.13 | 1.13 | 100821.0 |
| Sep 16, 2026 | 1.16 | 1.175 | 1.15 | 1.15 | 111002.0 |
| Sep 15, 2026 | 1.19 | 1.19 | 1.15 | 1.16 | 160369.0 |
| Sep 14, 2026 | 1.17 | 1.195 | 1.17 | 1.19 | 157856.0 |
| Sep 11, 2026 | 1.16 | 1.22 | 1.16 | 1.16 | 54298.00 |
| Sep 10, 2026 | 1.15 | 1.215 | 1.15 | 1.16 | 471786.0 |
| Sep 09, 2026 | 1.17 | 1.20 | 1.15 | 1.15 | 147563.0 |
| Sep 08, 2026 | 1.15 | 1.18 | 1.13 | 1.16 | 293707.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 60.73 |
| Oncolytics Biotech, Inc. | 0.4733 |
| Sangamo Therapeutics, Inc. | 0.15 |
| Sarepta Therapeutics, Inc. | 17.44 |
| Anixa Biosciences, Inc. | 2.84 |
Price Related Metrics
| PS Ratio | 2.824 |
| PEG Ratio | -0.0687 |
| Price to Book Value | 0.3423 |
| Earnings Yield | -243.9% |
| Market Cap | 38.53M |
| PEGY Ratio | -0.0687 |